Enhancing Chemotherapy Efficacy via an Autologous Erythrocyte-Anchoring Strategy with a Closed-System Drug-Transfer Device
- 19 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (1) , 429-441
Abstract
Chemotherapeutic drugs often fail to localize efficiently to tumors when administered intravenously, causing off-target effects. This study proposes an autologous erythrocyte (ER)-anchoring strategy to improve chemotherapy efficacy and reduce side effects. Utilizing a modified hemodialysis instrument, a closed-system drug-transfer device was developed for autologous ER procurement and immunogenicity mitigation. Doxorubicin (DOX) and indocyanine green (ICG) were encapsulated in autologous ERs and then modified with DSPE-PEG-FA. The final product, DOX-ICG@ER-D, was reintroduced into circulation to enhance chemotherapy. These obtained DOX-ICG@ER-D showed good stability, minimal cardiotoxicity, and extended circulation time. Compared to free DOX, DOX-ICG@ER-D had a higher accumulation of DOX in hepatocellular carcinoma and the release of DOX could be controlled by laser irradiation. Tumor-bearing rats treated by these DOX-ICG@ER-D demonstrated improved antitumor efficacy and reduced cardiotoxicity. Thus, this autologous ER-anchoring strategy offers a promising alternative to intravenous chemotherapy in the clinic.Keywords
Funding Information
- The Natural Science Foundation of Jiangsu Province (BK20221252)
- National Natural Science Foundation of China (52173128, 51973091)
This publication has 47 references indexed in Scilit:
- Fluid Therapy for Critically Ill Adults With SepsisJAMA, 2023
- Erythrocyte‐Inspired Functional Materials for Biomedical ApplicationsAdvanced Science, 2022
- Thermal‐Responsive MXene‐DNA Hydrogel for Near‐Infrared Light Triggered Localized Photothermal‐Chemo Synergistic Cancer TherapySmall, 2022
- Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastomaBioengineering & Translational Medicine, 2020
- Ultrafast glucose-responsive, high loading capacity erythrocyte to self-regulate the release of insulinActa Biomaterialia, 2018
- Remotely Controlled Red Blood Cell Carriers for Cancer Targeting and Near‐Infrared Light‐Triggered Drug Release in Combined Photothermal–ChemotherapyAdvanced Functional Materials, 2015
- Ca2+-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament slidingArchives of Biochemistry and Biophysics, 2014
- Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potentialAdvanced Drug Delivery Reviews, 2004
- Degradation Kinetics of Indocyanine Green in Aqueous SolutionJournal of Pharmaceutical Sciences, 2003
- The relation between membrane structure and NADH: (Acceptor) oxidoreductase activity of erythrocyte ghostsArchives of Biochemistry and Biophysics, 1969